My Personal CFO LLC Buys New Stake in Aflac Incorporated (NYSE:AFL)

My Personal CFO LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 734 shares of the financial services provider’s stock, valued at approximately $53,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Truist Financial Corp raised its stake in Aflac by 982.0% during the third quarter. Truist Financial Corp now owns 2,198,423 shares of the financial services provider’s stock worth $123,552,000 after acquiring an additional 1,995,240 shares in the last quarter. Invesco Ltd. increased its position in shares of Aflac by 62.4% during the 1st quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock worth $317,865,000 after purchasing an additional 1,897,212 shares in the last quarter. Great West Life Assurance Co. Can bought a new position in Aflac during the 3rd quarter valued at about $65,661,000. Envestnet Asset Management Inc. boosted its position in Aflac by 225.2% in the third quarter. Envestnet Asset Management Inc. now owns 1,076,386 shares of the financial services provider’s stock valued at $60,493,000 after buying an additional 745,346 shares in the last quarter. Finally, Maj Invest Holding A S grew its stake in Aflac by 16.5% during the third quarter. Maj Invest Holding A S now owns 5,061,371 shares of the financial services provider’s stock worth $325,902,000 after buying an additional 715,304 shares during the last quarter. Institutional investors own 66.22% of the company’s stock.

Insiders Place Their Bets

In other Aflac news, Director Masatoshi Koide sold 19,291 shares of the company’s stock in a transaction on Tuesday, February 14th. The shares were sold at an average price of $70.36, for a total transaction of $1,357,314.76. Following the completion of the sale, the director now owns 87,598 shares in the company, valued at approximately $6,163,395.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Masatoshi Koide sold 19,291 shares of Aflac stock in a transaction on Tuesday, February 14th. The stock was sold at an average price of $70.36, for a total transaction of $1,357,314.76. Following the completion of the sale, the director now directly owns 87,598 shares of the company’s stock, valued at $6,163,395.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 500 shares of the stock in a transaction dated Tuesday, January 3rd. The shares were sold at an average price of $71.98, for a total value of $35,990.00. Following the completion of the transaction, the director now directly owns 19,751 shares in the company, valued at approximately $1,421,676.98. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Aflac Trading Down 1.9 %

Aflac stock traded down $1.19 during mid-day trading on Friday, hitting $61.29. The stock had a trading volume of 7,331,290 shares, compared to its average volume of 2,445,937. The stock has a 50-day simple moving average of $69.23 and a two-hundred day simple moving average of $66.77. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $37.52 billion, a PE ratio of 9.33, a P/E/G ratio of 2.24 and a beta of 0.94. Aflac Incorporated has a 12 month low of $52.07 and a 12 month high of $74.01.

Aflac (NYSE:AFL – Get Rating) last issued its earnings results on Thursday, February 2nd. The financial services provider reported $1.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.08. The company had revenue of $4.01 billion for the quarter, compared to analyst estimates of $4.49 billion. Aflac had a net margin of 21.54% and a return on equity of 13.69%. The company’s revenue for the quarter was down 26.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.28 EPS. As a group, sell-side analysts forecast that Aflac Incorporated will post 5.59 EPS for the current year.

Analyst Upgrades and Downgrades

AFL has been the subject of a number of research analyst reports. Morgan Stanley cut their target price on shares of Aflac from $78.00 to $77.00 and set an “overweight” rating for the company in a research note on Friday, February 24th. StockNews.com initiated coverage on Aflac in a research note on Thursday. They issued a “hold” rating on the stock. JPMorgan Chase & Co. increased their target price on Aflac from $62.00 to $66.00 and gave the stock a “neutral” rating in a report on Friday, January 6th. Raymond James lifted their price target on Aflac from $74.00 to $77.00 and gave the company an “outperform” rating in a report on Monday, January 30th. Finally, Truist Financial increased their price objective on shares of Aflac from $65.00 to $70.00 and gave the stock a “hold” rating in a report on Monday, February 6th. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Aflac currently has an average rating of “Hold” and a consensus target price of $71.75.

Aflac Profile

(Get Rating)

Aflac, Inc is a holding company. engages in the provision of financial protection services. It operates through the followings segments: Aflac Japan and Aflac United States (U.S.). The Aflac Japan segment offers life insurance, death benefits, and cash surrender values. The Aflac U.S. segment sells voluntary supplemental insurance products for people who already have major medical or primary insurance coverage.